Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:24:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T14:13:40.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The record history now includes a new revision (v3.7.0) and the previous revision (v3.6.6) is removed, indicating an update to the study record’s metadata.
    Difference
    0.1%
    Check dated 2026-09-19T20:17:00.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A new revision line appears in the study record history, updating the version from v3.6.5 to v3.6.6. This reflects a platform release update applied to the page rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T18:39:50.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.6.5) added to replace the previous v3.6.4, indicating the study record was updated to a newer version.
    Difference
    0.1%
    Check dated 2026-08-08T17:10:02.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The study's history now includes a new revision entry labeled v3.6.4, and the previous revision v3.6.3 is removed from the log. This reflects an update to the record's revision history rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-07-25T10:21:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.